After multiple threats from President Donald Trump, the Office of the United States Trade Representatives (USTR) announced Friday, June 15, they will go-forward with 25 percent tariffs on approximately $50 billion worth of Chinese imports—including medical imaging equipment.
In a letter to the U.S. Preventative Services Task Force (USPSTF), the American College of Radiology (ACR), the Lung Cancer Alliance and the Society of Thoracic Surgeons urged for objectivity in the upcoming review of the USPSTF’s lung cancer screening recommendations.
In a blow to Medicare patients with metastatic cancers, the Centers for Medicare & Medicaid Services (CMS) announced it has rejected reimbursement coverage for 18F-sodium fluoride positron emission tomography (NaF PET) imaging.
The study in the latest edition of Research Policy, looking at the 2.3 percent excise tax imposed on medical devices in 2013, found it significantly reduced research and development investment, sales revenue, gross margins and earnings since ACA implementation in 2013.
The Medical Imaging and Technology Alliance (MITA) announced its strong support of a bipartisan letter from U.S. Reps. Erik Paulsen, R-Minnesota, and Scott Peters, D-California, urging United States Trade Representative (USTR) Robert Lighthizer to exempt $3 billion worth of medical devices from tariffs.
The FDA has proposed reclassifying medical image analyzers used in mammography for breast cancer, ultrasound for breast lesions, x-ray for lung nodules and x-ray for dental caries as class II medical devices instead of class III.
Health insurance giant Anthem implemented its controversial imaging policy in Colorado last fall which has limited CT and MRI coverage for the nearly one in five patients with private insurance in the state, according to a Denver Post report. Some experts question the motivation of the move.
On May 17, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the Value Initiative Industry Alliance—a collaboration among corporate community members that will help implement the organization’s Value Initiative and advance nuclear medicine.
On Tuesday, May 16, the vice president of the National Electrical Manufacturers Association (NEMA) testified in front of an Office of the United States Trade Representative (USTR) committee, stating the proposed tariffs on Chinese imports would equate to $2.25 billion in taxes on many of its members, which include medical imaging device manufacturers.
A recent Black Book Market Research survey of administrators from 709 hospitals and inpatient organizations found medical imaging among the most popular services hospitals are considering outsourcing to save money.
The U.S. leads 22 comparable countries in MRI price, availability and use, according to a data report published by the Kaiser Family Foundation. The report was recently presented at a forum held by the Kaiser Family Foundation and the Peterson Center on Healthcare in Washington, D.C.
In 2015, Medicare spent $762.1 million on imaging services in Massachusetts, with per beneficiary spending 14 percent higher than the average state. A Boston Business Journal report suggests increased imaging costs and higher utilization of imaging services are to blame.
Chris Tomlinson, VP of enterprise radiology at Jefferson Health and finance chair at the Association for Medical Imaging Management (AHRA), spoke with HealthImaging about these issues—and why the "commoditization” of imaging may be at the heart of the problem.
FDA Commissioner Scott Gottlieb, MD, said his administration is working on an updated “new regulatory framework” to promote the use of artificial intelligence (AI) in healthcare, and he expects medical imaging to be at the forefront of AI-based healthcare devices, according to a report published by The Hill.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) addressed two letters to Aetna recommending the health insurance giant alter its radiopharmaceutical coverage policy to include PET imaging agents dotatate and fluciclovine.